• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌梗死后索他洛尔对QT离散度的降低作用。

Reduction in QT dispersion by sotalol following myocardial infarction.

作者信息

Day C P, McComb J M, Matthews J, Campbell R W

机构信息

Department of Academic Cardiology, Freeman Hospital, Newcastle upon Tyne, U.K.

出版信息

Eur Heart J. 1991 Mar;12(3):423-7. doi: 10.1093/oxfordjournals.eurheartj.a059911.

DOI:10.1093/oxfordjournals.eurheartj.a059911
PMID:2040324
Abstract

Increased dispersion of ventricular recovery time is believed to be a substrate for serious ventricular arrhythmias. Class III antiarrhythmic drugs probably operate by decreasing dispersion through homogeneous prolongation of recovery time. A single surface QT value gives no information on recovery time dispersion but interlead variation in QT may be relevant. QTc dispersion was measured in 67 patients post myocardial infarction randomized to treatment with either sotalol or placebo. QTc dispersion was calculated as the difference between the maximum and minimum QTc in any surface electrocardiogram lead. Both maximum QTc and QTc dispersion varied considerably following infarction but throughout the 6-month follow-up period maximum QTc was significantly greater (P less than 0.05) and QTc dispersion significantly less (P less than 0.05) in patients on sotalol compared with placebo. These findings are in accord with expected changes in ventricular recovery time and provide strong support for the hypothesis that surface electrocardiogram QT variation reflects regional differences in ventricular recovery time.

摘要

心室复极时间离散度增加被认为是严重室性心律失常的一个基础。Ⅲ类抗心律失常药物可能通过均匀延长复极时间来减少离散度而起作用。单个体表QT值并不能提供关于复极时间离散度的信息,但QT间期的导联间差异可能与之相关。对67例心肌梗死后随机接受索他洛尔或安慰剂治疗的患者测量了QTc离散度。QTc离散度计算为任何体表心电图导联中最大QTc与最小QTc之间的差值。梗死发生后,最大QTc和QTc离散度均有相当大的变化,但在整个6个月的随访期内,与安慰剂相比,接受索他洛尔治疗的患者最大QTc显著更高(P<0.05),QTc离散度显著更低(P<0.05)。这些发现与心室复极时间的预期变化一致,并为体表心电图QT间期变化反映心室复极时间区域差异这一假说提供了有力支持。

相似文献

1
Reduction in QT dispersion by sotalol following myocardial infarction.心肌梗死后索他洛尔对QT离散度的降低作用。
Eur Heart J. 1991 Mar;12(3):423-7. doi: 10.1093/oxfordjournals.eurheartj.a059911.
2
QT dispersion: an indication of arrhythmia risk in patients with long QT intervals.QT离散度:长QT间期患者心律失常风险的一个指标。
Br Heart J. 1990 Jun;63(6):342-4. doi: 10.1136/hrt.63.6.342.
3
Repolarization changes in a double-blind crossover study of dofetilide versus sotalol in the treatment of ventricular tachycardia.多非利特与索他洛尔治疗室性心动过速的双盲交叉研究中的复极化变化
Pacing Clin Electrophysiol. 2000 Nov;23(11 Pt 2):1935-8. doi: 10.1111/j.1540-8159.2000.tb07056.x.
4
QT dispersion and early arrhythmic risk during acute myocardial infarction.急性心肌梗死期间的QT离散度与早期心律失常风险
Angiology. 1999 Mar;50(3):209-15. doi: 10.1177/000331979905000305.
5
Effects of amiodarone, sematilide, and sotalol on QT dispersion.
Am J Cardiol. 1994 Nov 1;74(9):896-900. doi: 10.1016/0002-9149(94)90582-7.
6
A comparison of the long-term effects of sotalol and atenolol on QT interval and arrhythmias after myocardial infarction.索他洛尔与阿替洛尔对心肌梗死后QT间期及心律失常长期影响的比较。
Eur Heart J. 1988 Jan;9(1):24-31.
7
QT dispersion and early arrhythmic risk during acute myocardial infarction.急性心肌梗死期间的QT离散度与早期心律失常风险
G Ital Cardiol. 1999 Dec;29(12):1438-44.
8
Metabolic management of coronary heart disease: adjunctive treatment with trimetazidine decreases QT dispersion in patients with a first acute myocardial infarction.
Cardiovasc Drugs Ther. 2001 Jul;15(4):315-21. doi: 10.1023/a:1012706630965.
9
Electrophysiological effects of intravenous sotalol in acute myocardial infarction: a double-blind placebo-controlled study.静脉注射索他洛尔对急性心肌梗死的电生理效应:一项双盲安慰剂对照研究。
Eur Heart J. 1990 Jan;11(1):35-42. doi: 10.1093/oxfordjournals.eurheartj.a059589.
10
[Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].索他洛尔、普罗帕酮和氟卡尼:无器质性心脏病受试者心室复极化的多参数比较分析
Cardiologia. 1996 Jul;41(7):645-51.

引用本文的文献

1
QT Dispersion and Drug-Induced Torsade de Pointes.QT离散度与药物诱发的尖端扭转型室性心动过速
Cureus. 2021 Jan 25;13(1):e12895. doi: 10.7759/cureus.12895.
2
ECG Changes in Melanoma Patients Undergoing Cancer Therapy-Data From the ECoR Registry.接受癌症治疗的黑色素瘤患者的心电图变化——来自ECoR注册中心的数据
J Clin Med. 2020 Jun 30;9(7):2060. doi: 10.3390/jcm9072060.
3
Comparison between QT Interval Parameters in Type 2 Diabetic and Nondiabetic Patients with Non-ST Elevation Myocardial Infarction.2型糖尿病合并非ST段抬高型心肌梗死患者与非糖尿病患者QT间期参数的比较。
J Tehran Heart Cent. 2014;9(4):166-73. Epub 2014 Jul 6.
4
Nebivolol therapy improves QTc and QTcd parameters in heart failure patients.奈必洛尔治疗可改善心力衰竭患者的QTc和QTcd参数。
Cardiovasc J Afr. 2012 May;23(4):191-3. doi: 10.5830/CVJA-2011-046.
5
Nondipolar electrocardiographic components and myocardial heterogeneity.非偶极心电图成分与心肌异质性
Ann Noninvasive Electrocardiol. 2009 Apr;14(2):103-7. doi: 10.1111/j.1542-474X.2009.00296.x.
6
The association of QT dispersion and QT dispersion ratio with extent and severity of coronary artery disease.QT离散度及QT离散度比值与冠状动脉疾病范围及严重程度的关联。
Ann Noninvasive Electrocardiol. 2006 Jan;11(1):43-51. doi: 10.1111/j.1542-474X.2006.00081.x.
7
QT interval in patients with unstable angina and non-Q wave myocardial infarction.不稳定型心绞痛和非Q波心肌梗死患者的QT间期
Ann Noninvasive Electrocardiol. 2002 Oct;7(4):343-8. doi: 10.1111/j.1542-474x.2002.tb00183.x.
8
Improving the reproducibility of QT dispersion measures.提高QT离散度测量的可重复性。
Ann Noninvasive Electrocardiol. 2001 Apr;6(2):143-52. doi: 10.1111/j.1542-474x.2001.tb00099.x.
9
Ventricular repolarization, T-wave genesis, and risk prediction.心室复极化、T波形成与风险预测。
Ann Noninvasive Electrocardiol. 2001 Jan;6(1):1-4. doi: 10.1111/j.1542-474x.2001.tb00079.x.
10
Is ventricular repolarization heterogeneity a cause of serious ventricular tachyarrhythmias in aortic valve stenosis?心室复极异质性是主动脉瓣狭窄时严重室性快速性心律失常的病因吗?
Clin Cardiol. 2000 Jun;23(6):449-52. doi: 10.1002/clc.4960230615.